# A Study of Lispro Formulations in Healthy Participants

> **NCT02293551** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 54 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Lispro

## Key facts

- **NCT ID:** NCT02293551
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2025-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02293551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02293551, "A Study of Lispro Formulations in Healthy Participants". Retrieved via MORVS 2026-10-19 from https://api.morvs.ai/clinical/NCT02293551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*